Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy‐proven diabetic nephropathy
Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findin...
Saved in:
Published in | Diabetic medicine Vol. 37; no. 12; pp. 2143 - 2152 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims
Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development.
Methods
This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions.
Results
Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions (P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model.
Conclusions
Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy.
What’s new?
In diabetic nephropathy, the relationship between two histological vascular lesions in kidney tissues and future cardiovascular events is unclear. We evaluated hyalinosis in small arterioles of < 150 µm diameter, and intimal thickening in double‐layered large arteries of 150–300 µm diameter. Arteriolar hyalinosis was significantly associated with cardiovascular events, whereas intimal thickening in large arteries was not.
Systolic blood pressure was strongly related to arteriolar hyalinosis but not to intimal thickening in large arteries, suggesting that hypertensive injury of smaller arterioles in the kidneys was more strongly associated with cardiovascular events and mortality than that of larger arteries in diabetic nephropathy. |
---|---|
AbstractList | Aims
Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development.
Methods
This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions.
Results
Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions (P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model.
Conclusions
Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy.
What’s new?
In diabetic nephropathy, the relationship between two histological vascular lesions in kidney tissues and future cardiovascular events is unclear. We evaluated hyalinosis in small arterioles of < 150 µm diameter, and intimal thickening in double‐layered large arteries of 150–300 µm diameter. Arteriolar hyalinosis was significantly associated with cardiovascular events, whereas intimal thickening in large arteries was not.
Systolic blood pressure was strongly related to arteriolar hyalinosis but not to intimal thickening in large arteries, suggesting that hypertensive injury of smaller arterioles in the kidneys was more strongly associated with cardiovascular events and mortality than that of larger arteries in diabetic nephropathy. Abstract Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development. Methods This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions. Results Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions ( P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model. Conclusions Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy. What’s new? In diabetic nephropathy, the relationship between two histological vascular lesions in kidney tissues and future cardiovascular events is unclear. We evaluated hyalinosis in small arterioles of < 150 µm diameter, and intimal thickening in double‐layered large arteries of 150–300 µm diameter. Arteriolar hyalinosis was significantly associated with cardiovascular events, whereas intimal thickening in large arteries was not. Systolic blood pressure was strongly related to arteriolar hyalinosis but not to intimal thickening in large arteries, suggesting that hypertensive injury of smaller arterioles in the kidneys was more strongly associated with cardiovascular events and mortality than that of larger arteries in diabetic nephropathy. AimsDiabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development.MethodsThis retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions.ResultsOf the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions (P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model.ConclusionsArteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy. Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development. This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy-proven diabetic nephropathy, with a median follow-up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions. Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow-up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan-Meier analysis than those without these lesions (P = 0.005, log-rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model. Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy. |
Author | Matsui, M. Nishimoto, M. Eriguchi, M. Samejima, K. Tsuruya, K. Saito, Y. Murashima, M. Yamada, H. Akai, Y. Shiiki, H. Dohi, K. Iwano, M. Morimoto, K. Tanabe, K. Kanki, T. Kanauchi, M. |
Author_xml | – sequence: 1 givenname: K. surname: Morimoto fullname: Morimoto, K. organization: Nara Medical University – sequence: 2 givenname: M. surname: Matsui fullname: Matsui, M. organization: Nara Medical University – sequence: 3 givenname: K. orcidid: 0000-0001-8273-5155 surname: Samejima fullname: Samejima, K. email: ksame@naramed-u.ac.jp organization: Nara Medical University – sequence: 4 givenname: T. surname: Kanki fullname: Kanki, T. organization: Nara Medical University – sequence: 5 givenname: M. surname: Nishimoto fullname: Nishimoto, M. organization: Nara Medical University – sequence: 6 givenname: K. surname: Tanabe fullname: Tanabe, K. organization: Nara Medical University – sequence: 7 givenname: M. surname: Murashima fullname: Murashima, M. organization: Nara Medical University – sequence: 8 givenname: M. surname: Eriguchi fullname: Eriguchi, M. organization: Nara Medical University – sequence: 9 givenname: Y. surname: Akai fullname: Akai, Y. organization: Nara Medical University – sequence: 10 givenname: M. surname: Iwano fullname: Iwano, M. organization: Nara Medical University – sequence: 11 givenname: H. surname: Shiiki fullname: Shiiki, H. organization: Nara Medical University – sequence: 12 givenname: H. surname: Yamada fullname: Yamada, H. organization: Nara Medical University – sequence: 13 givenname: M. surname: Kanauchi fullname: Kanauchi, M. organization: Nara Medical University – sequence: 14 givenname: K. surname: Dohi fullname: Dohi, K. organization: Nara Medical University – sequence: 15 givenname: K. surname: Tsuruya fullname: Tsuruya, K. organization: Nara Medical University – sequence: 16 givenname: Y. surname: Saito fullname: Saito, Y. organization: Nara Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32276289$$D View this record in MEDLINE/PubMed |
BookMark | eNp10dFq1TAYB_AgE3c2vfAFJOCNgt2SJk3SS5lTBxNB9Lqk6dc1syepSbrROx_Bd_DNfBJz1jMvBuYmEH7fn_D9j9CB8w4Qek7JCc3ntNvCCeWM0EdoQ7ngRcVreoA2RPKyYETSQ3QU4zUhtKxZ_QQdsrKUolT1Bv3-Ak6PWIcEwfpRBzwserTORxvfYOcTti7ZbSZpsOY7OOuu8hPO8gr2Y5CljVjH6I3VCTp8a9OAjQ6d9Tc6mnmXCzfgUtzNTuCnEVbUWj_F5c_PX1PwGeDO6haSNdjBNAQ_6TQsT9HjXo8Rnu3vY_Tt_fnXs4_F5ecPF2dvLwvDBaWFbCklipCKkVoZ0QtZSaIFyIqrlkjJOtUC0X0FteyFULTkJSeVaVsp6p7X7Bi9WnPzX37MEFOztdHAOGoHfo5NyZRSVBAmMn35gF77OeRNZsUFIUxxyrJ6vSoTfIwB-mYKeZdhaShpds01ubnmrrlsX-wT53YL3T95X1UGpyu4tSMs_09q3n06XyP_AuQ1pyU |
CitedBy_id | crossref_primary_10_1038_s41440_023_01197_y crossref_primary_10_1007_s40200_021_00765_8 crossref_primary_10_1111_dom_15347 crossref_primary_10_1136_bmjdrc_2020_001863 crossref_primary_10_1113_EP091520 crossref_primary_10_3390_molecules27248732 crossref_primary_10_34067_KID_0000000000000126 crossref_primary_10_1007_s10157_022_02221_0 crossref_primary_10_1186_s12902_022_00935_6 crossref_primary_10_1007_s10157_023_02433_y |
Cites_doi | 10.1253/circj.CJ-11-1033 10.1681/ASN.2007020220 10.2337/dc10-0555 10.1093/ndt/gft349 10.2215/CJN.04980515 10.1007/s10157-006-0453-4 10.1681/ASN.2010010010 10.1093/ndt/gfu250 10.1016/0046-8177(94)90039-6 10.1159/000443440 10.1111/j.2040-1124.2010.00074.x 10.2337/diab.24.1.1 10.1046/j.1523-1755.2002.00171.x 10.1373/clinchem.2008.103556 10.1681/ASN.2007010067 10.1136/bmj.317.7160.703 10.1159/000371727 10.1056/NEJMoa011303 10.2337/dc13-0298 10.1053/j.ajkd.2008.12.034 10.1097/00041552-199801000-00012 10.1007/s12013-015-0526-7 10.1046/j.1523-1755.2003.00712.x |
ContentType | Journal Article |
Copyright | 2020 Diabetes UK 2020 Diabetes UK. Diabetic Medicine © 2020 Diabetes UK |
Copyright_xml | – notice: 2020 Diabetes UK – notice: 2020 Diabetes UK. – notice: Diabetic Medicine © 2020 Diabetes UK |
DBID | NPM AAYXX CITATION 7T5 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1111/dme.14301 |
DatabaseName | PubMed CrossRef Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef Genetics Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef Genetics Abstracts PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Nursing |
EISSN | 1464-5491 |
EndPage | 2152 |
ExternalDocumentID | 10_1111_dme_14301 32276289 DME14301 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Ministry of Health, Labour and Welfare of Japan funderid: 15K19462; 25293187 – fundername: Takeda Science Foundation – fundername: Ministry of Health, Labour and Welfare of Japan grantid: 15K19462 – fundername: Ministry of Health, Labour and Welfare of Japan grantid: 25293187 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RWI RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 XV2 YFH YUY ZGI ZXP ZZTAW ~IA ~WT NPM AAYXX CITATION 7T5 8FD FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4611-7b11080053098c6f67570a6e7548b0773d8be0af5e97f6681242405cbb769f493 |
IEDL.DBID | DR2 |
ISSN | 0742-3071 |
IngestDate | Fri Aug 16 04:28:24 EDT 2024 Thu Oct 10 20:38:40 EDT 2024 Fri Aug 23 00:54:58 EDT 2024 Sat Sep 28 08:34:03 EDT 2024 Sat Aug 24 01:04:18 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | 2020 Diabetes UK. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4611-7b11080053098c6f67570a6e7548b0773d8be0af5e97f6681242405cbb769f493 |
Notes | These authors contributed equally to this study ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8273-5155 |
OpenAccessLink | http://hdl.handle.net/10564/3780 |
PMID | 32276289 |
PQID | 2460038413 |
PQPubID | 1006515 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2388816036 proquest_journals_2460038413 crossref_primary_10_1111_dme_14301 pubmed_primary_32276289 wiley_primary_10_1111_dme_14301_DME14301 |
PublicationCentury | 2000 |
PublicationDate | December 2020 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: December 2020 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Diabetic medicine |
PublicationTitleAlternate | Diabet Med |
PublicationYear | 2020 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 1994; 266 2007; 18 2010; 33 1988; 1 2010; 21 2013; 36 2010; 1 2009; 53 2002; 61 2015; 72 2015; 30 2015; 41 1998; 317 1975; 24 1994; 25 2016; 41 2008; 54 2014; 29 1998; 7 2007; 11 2003; 63 2012; 76 2001; 345 2016; 11 Hwa JJ (e_1_2_9_26_1) 1994; 266 Tracy RE (e_1_2_9_21_1) 1988; 1 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_13_1 e_1_2_9_12_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 |
References_xml | – volume: 29 start-page: 109 year: 2014 end-page: 118 article-title: Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy publication-title: Nephrol Dial Transplant – volume: 63 start-page: 225 year: 2003 end-page: 232 article-title: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) publication-title: Kidney Int – volume: 1 start-page: 212 year: 2010 end-page: 228 article-title: Report of the committee on the classification and diagnostic criteria of diabetes mellitus publication-title: J Diabetes Investig – volume: 41 start-page: 66 year: 2015 end-page: 72 article-title: Smoking‐related glomerulopathy: expanding the morphologic spectrum publication-title: Am J Nephrol – volume: 7 start-page: 71 year: 1998 end-page: 78 article-title: Heterogeneity of endothelial function within the circulation publication-title: Curr Opin Nephrol Hypertens – volume: 345 start-page: 851 year: 2001 end-page: 860 article-title: Renoprotective effect of the angiotensin‐receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes publication-title: N Engl J Med – volume: 1 start-page: 420 year: 1988 end-page: 427 article-title: Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program publication-title: Mod Pathol – volume: 30 start-page: 257 year: 2015 end-page: 266 article-title: Renal histologic changes and the outcome in patients with diabetic nephropathy publication-title: Nephrol Dial Transplant – volume: 18 start-page: 2135 year: 2007 end-page: 2142 article-title: Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study publication-title: J Am Soc Nephrol – volume: 53 start-page: 982 year: 2009 end-page: 992 article-title: Revised equations for estimated GFR from serum creatinine in Japan publication-title: Am J Kidney Dis – volume: 25 start-page: 1213 year: 1994 end-page: 1227 article-title: Insudative lesions—their pathogenesis and association with glomerular obsolescence in diabetes: a dynamic hypothesis based on single views of advancing human diabetic nephropathy publication-title: Hum Pathol – volume: 76 start-page: 1526 year: 2012 end-page: 1532 article-title: Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial publication-title: Circ J – volume: 61 start-page: 648 year: 2002 end-page: 654 article-title: Cigarette smoking and vascular pathology in renal biopsies publication-title: Kidney Int – volume: 72 start-page: 751 year: 2015 end-page: 756 article-title: The endothelium as a target for the treatment of heart failure publication-title: Cell Biochem Biophys – volume: 18 start-page: 2644 year: 2007 end-page: 2648 article-title: End‐stage renal disease in the United States: an update from the United States Renal Data System publication-title: J Am Soc Nephrol – volume: 33 start-page: 1395 year: 2010 end-page: 1402 article-title: Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation publication-title: Diabetes Care – volume: 266 start-page: H952 year: 1994 end-page: H958 article-title: Comparison of acetylcholine‐dependent relaxation in large and small arteries of rat mesenteric vascular bed publication-title: Am J Physiol – volume: 36 start-page: 3655 year: 2013 end-page: 3662 article-title: Long‐term outcomes of Japanese type 2 diabetic patients with biopsy‐proven diabetic nephropathy publication-title: Diabetes Care – volume: 54 start-page: 1379 year: 2008 end-page: 1385 article-title: Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden publication-title: Clin Chem – volume: 11 start-page: 41 year: 2007 end-page: 50 article-title: Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease publication-title: Clin Exp Nephrol – volume: 41 start-page: 374 year: 2016 end-page: 383 article-title: Relationship between type of hypertension and renal arteriolosclerosis in chronic glomerular disease publication-title: Kidney Blood Press Res – volume: 21 start-page: 556 year: 2010 end-page: 563 article-title: Renal Pathology Society. Pathologic classification of diabetic nephropathy publication-title: J Am Soc Nephrol – volume: 24 start-page: 1 year: 1975 end-page: 9 article-title: Onset and progression of diabetic glomerulosclerosis; a prospective study based on serial renal biopsies publication-title: Diabetes – volume: 317 start-page: 703 year: 1998 end-page: 713 article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group publication-title: BMJ – volume: 11 start-page: 593 year: 2016 end-page: 601 article-title: Prognostic value of tubulointerstitial lesions, urinary ‐acetyl‐β‐ ‐glucosaminidase, and urinary β2‐microglobulin in patients with type 2 diabetes and biopsy‐proven diabetic nephropathy publication-title: Clin J Am Soc Nephrol – ident: e_1_2_9_17_1 doi: 10.1253/circj.CJ-11-1033 – ident: e_1_2_9_2_1 doi: 10.1681/ASN.2007020220 – ident: e_1_2_9_15_1 doi: 10.2337/dc10-0555 – ident: e_1_2_9_7_1 doi: 10.1093/ndt/gft349 – ident: e_1_2_9_9_1 doi: 10.2215/CJN.04980515 – ident: e_1_2_9_11_1 doi: 10.1007/s10157-006-0453-4 – ident: e_1_2_9_5_1 doi: 10.1681/ASN.2010010010 – ident: e_1_2_9_8_1 doi: 10.1093/ndt/gfu250 – ident: e_1_2_9_18_1 doi: 10.1016/0046-8177(94)90039-6 – ident: e_1_2_9_19_1 doi: 10.1159/000443440 – ident: e_1_2_9_12_1 doi: 10.1111/j.2040-1124.2010.00074.x – ident: e_1_2_9_27_1 doi: 10.2337/diab.24.1.1 – ident: e_1_2_9_22_1 doi: 10.1046/j.1523-1755.2002.00171.x – ident: e_1_2_9_13_1 doi: 10.1373/clinchem.2008.103556 – ident: e_1_2_9_14_1 doi: 10.1681/ASN.2007010067 – ident: e_1_2_9_20_1 doi: 10.1681/ASN.2007010067 – volume: 1 start-page: 420 year: 1988 ident: e_1_2_9_21_1 article-title: Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program publication-title: Mod Pathol contributor: fullname: Tracy RE – ident: e_1_2_9_16_1 doi: 10.1136/bmj.317.7160.703 – ident: e_1_2_9_23_1 doi: 10.1159/000371727 – volume: 266 start-page: H952 year: 1994 ident: e_1_2_9_26_1 article-title: Comparison of acetylcholine‐dependent relaxation in large and small arteries of rat mesenteric vascular bed publication-title: Am J Physiol contributor: fullname: Hwa JJ – ident: e_1_2_9_3_1 doi: 10.1056/NEJMoa011303 – ident: e_1_2_9_6_1 doi: 10.2337/dc13-0298 – ident: e_1_2_9_10_1 doi: 10.1053/j.ajkd.2008.12.034 – ident: e_1_2_9_25_1 doi: 10.1097/00041552-199801000-00012 – ident: e_1_2_9_24_1 doi: 10.1007/s12013-015-0526-7 – ident: e_1_2_9_4_1 doi: 10.1046/j.1523-1755.2003.00712.x |
SSID | ssj0012939 |
Score | 2.440077 |
Snippet | Aims
Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly... Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly... Abstract Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which... AimsDiabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly... AIMSDiabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2143 |
SubjectTerms | Biopsy Cardiovascular diseases Diabetes Diabetes mellitus (non-insulin dependent) Diabetic nephropathy Diuretics Lesions Microvasculature Nephropathy Risk factors Veins & arteries |
Title | Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy‐proven diabetic nephropathy |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.14301 https://www.ncbi.nlm.nih.gov/pubmed/32276289 https://www.proquest.com/docview/2460038413 https://search.proquest.com/docview/2388816036 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwEB1VlUBseJRXSkEGsWBBqjycOBErBK0qpMuiolIXSJHtjEVUmlyRexe3Kz6Bf-DP-BJmnIe4ICTELkrGSmJ7Zs6Mx8cAz12EzprYhbW2MpQpkh0ssQ6lLQi9mriOM97gvHifn5zJd-fZ-Q68mvbCDPwQc8KNNcPba1ZwbfpflLy-RFLz1O_dYiI9BkSnM3UUu7FyoOBMOL8Sj6xCXMUzt9z2RX8AzG286h3O8S34OH3qUGdycbhemUN79RuL43_-y224OQJR8XqYOXdgB9s9uL4Yl9r34NqYR7gL30-RJX3xZ8ORsPi0IfTedn3TvxRttxJNu2ouSYRr5y-QMy10S3zmIvOxGZJk0ws9TgasBSeAhd2qhhWeTarntkNh-yBkmm7Zb358_cbpD2zFkC5urGhxyYc8EIbd3IOz46MPb07C8WyH0Mo8jkNleP8Bm4CoLGzuKG5Rkc5RUQRlIqXSujAYaZdhqVzOJGmSsEdmjVF56WSZ3ofdtmvxIYjMFNppabVWRrqEIjBEpZWmSDSJnU4CeDaNcrUcKDyqKfShjq98xwdwMI1_NWpxXyUy55VT8vMBPJ0fk_7xoopusVuTTFoUBZ_VnQfwYJg381vIWJKvKcoAXvjR__vrq7eLI3-x_--ij-BGwsG_r605gN3VlzU-JoS0Mk-8KvwEFegPcQ |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwEB1VRTw2PMqjgQIGsWBBqjycOJHYINrqAr1dVK3UDYpsxxZR2-SK5C4uKz6Bf-DP-BJmnIe4ICTELkrGSmL7zON4PAZ4YQNjtQqtX0rNfR4b1IO5KX2uM_ReVViGCW1wnh-ls1P-_iw524DX416Yvj7ERLgRMpy-JoATIf0LystLgziPafPWFYR7QrDcO56KR5Ehy_sinBExLOFQV4jyeKam69boDxdz3WN1JufgFnwcP7bPNDnfXXZqV3_5rY7j__7Nbbg5-KLsTT957sCGqbfg2nxYbd-CqwOVcBe-HxuSdPmfFQXD7NMKHfi6aav2FaubjlV1V12iCKXPnxsiW_AWu6A886GZQcmqZXKYD6ZkxAEzvZYQy1xBqZba9rntvZCqmkW7-vH1GzEgpmY9Y1xpVpsFnfOAbuzqHpwe7J-8nfnD8Q6-5mkY-kLRFgTSAkGe6dTiEIpApkZgEKUCIeIyUyaQNjG5sCnVSePofiRaKZHmlufxfdism9psA0tUJq3kWkqhuI0wCDNGSCExGI1CKyMPno_DXCz6Kh7FGP1gxxeu4z3YGSdAMQC5LSKe0uIpmnoPnk2PEYK0riJr0yxRJs6yjI7rTj140E-c6S2oL9HcZLkHL93w__31xd583108_HfRp3B9djI_LA7fHX14BDci4gJcqs0ObHafl-YxOkydeuJw8RMBfROR |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRVRceBQogQIGceBAqjwcOxEnxHZVHluhiko9IEW2Y4uoNFmR7GE58RP4D_wzfgkzeYkFISFuUTJWEtsz88348xjgiQusMzp0fqEM93ls0Q5mtvC5SRG96rAIE9rgvDgWR6f89VlytgXPx70wfX2IKeFGmtHZa1LwZeF-UfLiwqKax7R36xIXcUSR1-xkqh1Ffizra3BGlGAJh7JCROOZmm46oz8Q5iZg7TzO_Bp8GL-1J5qcH6xafWC-_FbG8T9_5jpcHZAoe9FPnRuwZatd2FkMa-27cHlIJNyE7yeWJDv2Z0mhMPu4Rvhe1U3ZPGNV3bKyassLFCHy_LmlVAveYp-IZT40syhZNkwNs8EWjDLAzGzQYVlXTqqhtj2zvRfSZb1s1j--fqP8h61Yny8uDavskk55QBC7vgWn88P3L4_84XAH33ARhr7UtAGBbECQpUY4DFxkoISVGELpQMq4SLUNlEtsJp2gKmkcwUditJYiczyLb8N2VVf2DrBEp8opbpSSmrsIQzBrpZIKQ9EodCry4PE4yvmyr-GRj7EPdnzedbwH--P454MaN3nEBS2doqP34NH0GBWQVlVUZesVysRpmtJh3cKDvX7eTG9Ba4nOJs08eNqN_t9fn88Wh93F3X8XfQg772bz_O2r4zf34EpEiYCOZ7MP2-3nlb2PaKnVDzqt-AnDdRJA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Renal+arteriolar+hyalinosis%2C+not+intimal+thickening+in+large+arteries%2C+is+associated+with+cardiovascular+events+in+people+with+biopsy-proven+diabetic+nephropathy&rft.jtitle=Diabetic+medicine&rft.au=Morimoto%2C+K&rft.au=Matsui%2C+M&rft.au=Samejima%2C+K&rft.au=Kanki%2C+T&rft.date=2020-12-01&rft.eissn=1464-5491&rft.volume=37&rft.issue=12&rft.spage=2143&rft_id=info:doi/10.1111%2Fdme.14301&rft_id=info%3Apmid%2F32276289&rft.externalDocID=32276289 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon |